Newsletter | November 22, 2021

11.22.21 -- Why Supply Chain Operations Are Hot

Exclusive Articles
From SPAC To De-SPAC, A Tutorial From A CFO: Part 2
This is part two of a Q&A with Michael Byrnes, CFO at eFFECTOR Therapeutics, a company currently in the process of de-SPAC-ing a May 2021 announced special purpose acquisition company (SPAC) with Locust Walk Acquisition Corp.
A Dynamic Supply Chain Can Help Biopharmas Survive And Thrive
After decades of back-office obscurity, supply chain operations are suddenly a focal point in life sciences boardrooms and executive suites. The old supply chain playbooks no longer seem relevant.
Long Hauler In The Antibiotics Space

For Ted Schroeder, CEO of Nabriva Therapeutics, the road of his biopharma career led him into the antibiotics space, a mighty steep climb in the biopharma industry.

Web-Exclusive Content
Slippery Slope: Competitive Differentiation In Biopharma

When is it time for an emerging biopharma company to truly emerge, and what goes into its competitive positioning? Biopharma industry veteran Allan Shaw shares insight into developing a differentiation strategy on an increasingly crowded, and evermore complex, playing field.

November 2021 Digital Edition

Inside you will find more on:

  • Exclusive CEO Interviews
  • Manufacturing In The U.S.
  • Hiring Tips
  • Companies To Watch

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.